Clinical Trial Update: Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial from Radboud University Medical Center is evaluating immuno-PET imaging to assess responses to an immune checkpoint inhibitor i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Radboud University Medical Center | Conditions: NSCLC | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING